Medivox Rx Technologies Inc Pittsburgh, PA - 15213

Medivox Rx Technologies Inc is categorized under Media Buying Services in Pittsburgh, PA and active since 2009.

Medivox Rx Technologies Inc was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a Media Buying Services business, which does work in the B2B market, and is classified as a Media Buying Services, under code number 3222190 by the NAICS.

If you are seeking more information, feel free to contact Greg Jakub, President at the company’s single location by writing to 5001 Baum Boulevard # 770, Pittsburgh, Pennsylvania PA 15213 or by phoning (412) 621-0902. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Medivox Rx Technologies Inc
Contact Person: Greg Jakub, President
Address: 5001 Baum Boulevard # 770, Pittsburgh, Pennsylvania 15213
Phone Number: (412) 621-0902
Website Address: rxtalks.com
Annual Revenue (USD): Unknown
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Media Buying Services
SIC Code: 7319
NAICS Code: 3222190
Share This Business:

Medivox Rx Technologies Inc was started in 2009 to provide professional Media Buying Services under the SIC code 7319 and NAICS code 3222190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Greg Jakub, President for inquiries that concern Medivox Rx Technologies Inc by calling the company number (412) 621-0902, as your correspondence is most welcome. Additionally, the physical location of the single location of Medivox Rx Technologies Inc can be found at the coordinates 40.45517,-79.94474 as well as the street address 5001 Baum Boulevard # 770 in Pittsburgh, Pennsylvania 15213.

For its online presence, you may visit Medivox Rx Technologies Inc’s website at rxtalks.com and engage with its social media outlets through on Twitter and on Facebook.